Hemostod
HemostOD is a Swiss-based preclinical biotech company that engineers and manufactures universal platelets inspired by platelet biology to save lives. They develop innovative solutions for thrombocytopenia, tissue-targeted cargo delivery, regenerative medicine, and culture of therapeutic stem cells. Their proprietary platform enables scalable production of engineered platelets for various medical applications.
Industries
Nr. of Employees
small (1-50)
Products
Engineered universal platelets (HLA-null)
In vitro–manufactured platelets derived from an immortalized hematopoietic progenitor cell line, engineered to be HLA-null to reduce immune refractoriness and intended for transfusion use in thrombocytopenia.
Platelet-derived targeted delivery vehicles
Platelet-based carriers engineered to shield and deliver nucleic acids (miRNA/siRNA) or proteins to specific target tissues.
Platelet lysate for therapeutic stem cell culture
Platelet-derived lysate produced from engineered platelets intended as a supplement to boost proliferation of therapeutic stem cells in culture.
Engineered universal platelets (HLA-null)
In vitro–manufactured platelets derived from an immortalized hematopoietic progenitor cell line, engineered to be HLA-null to reduce immune refractoriness and intended for transfusion use in thrombocytopenia.
Platelet-derived targeted delivery vehicles
Platelet-based carriers engineered to shield and deliver nucleic acids (miRNA/siRNA) or proteins to specific target tissues.
Platelet lysate for therapeutic stem cell culture
Platelet-derived lysate produced from engineered platelets intended as a supplement to boost proliferation of therapeutic stem cells in culture.
Services
Collaborative preclinical development and translation
Joint development projects with clinical and transfusion partners to characterize engineered platelet products and advance them toward clinical evaluation.
Pre-industrialization and bioprocess engineering support
Process development and scale-up activities in collaboration with specialized bioprocess centers to adapt laboratory methods for larger-scale production.
Collaborative preclinical development and translation
Joint development projects with clinical and transfusion partners to characterize engineered platelet products and advance them toward clinical evaluation.
Pre-industrialization and bioprocess engineering support
Process development and scale-up activities in collaboration with specialized bioprocess centers to adapt laboratory methods for larger-scale production.
Expertise Areas
- Platelet biomanufacturing
- Cell line engineering and immortalization
- Megakaryocyte differentiation
- Targeted cargo delivery using cell-derived carriers
Key Technologies
- Microfluidic bioreactors for cell fragmentation
- Cell immortalization techniques
- Megakaryocyte differentiation protocols
- Genetic/cellular surface engineering